Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V96.8.2814.H8002814_2814_2821PMID 11023516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

  2000cited by this paper
• First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation

  2000cited by this paper
• Epstein–Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond–Blackfan anemia

  2000cited by this paper
• A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.

  1999cited by this paper
• Current use of polyclonal antilymphocyte antibody preparations.

  1999cited by this paper
• HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

  1999cited by this paper
• H2-M3–Restricted T Cells in Bacterial Infection

  1999cited by this paper
• Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children.

  1999cited by this paper
• T Cell Affinity Maturation by Selective Expansion during Infection

  1999cited by this paper
• Evolution of a Complex T Cell Receptor Repertoire during Primary and Recall Bacterial Infection

  1998cited by this paper
• A New Look at T Cells

  1998cited by this paper
• Analysis of Gag-specific Cytotoxic T Lymphocytes in Simian Immunodeficiency Virus–infected Rhesus Monkeys by Cell Staining with a Tetrameric Major Histocompatibility Complex Class I–Peptide Complex

  1998cited by this paper
• Coordinate regulation of complex T cell populations responding to bacterial infection.

  1998cited by this paper
• Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

  1998cited by this paper
• Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

  1998cited by this paper
• Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo

  1998cited by this paper
• Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients.

  1998cited by this paper
• Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.

  1998cited by this paper
• The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.

  1998cited by this paper
• Stem cell transplantation for severe autoimmune diseases: progress and problems.

  1998cited by this paper
• Immunodeficiency-associated lymphoproliferative disorders.

  1998cited by this paper
• Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.

  1998cited by this paper
• Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

  1998cited by this paper
• Biology and adoptive cell therapy of Epstein‐Barr virus‐associated lymphoproliferative disorders in recipients of marrow allografts

  1997cited by this paper
• Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.

  1997cited by this paper
• Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.

  1997cited by this paper
• The Use of Mobilized Peripheral Blood Stem Cells from Normal Donors for Allografting

  1997cited by this paper
• Bone marrow transplantation for therapy in autoimmune disease

  1997cited by this paper
• Allogeneic blood stem cell transplantation

  1997cited by this paper
• Immunodominant and subdominant CTL responses to Listeria monocytogenes infection.

  1997cited by this paper
• Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes

  1996cited by this paper
• Phenotypic Analysis of Antigen-Specific T Lymphocytes

  1996cited by this paper
• The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

  1996cited by this paper
• FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors.

  1996cited by this paper
• The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.

  1996cited by this paper
• Hematology: Basic Principles and Practice

  1995cited by this paper
• Hematology, Basic Principles and Practice, 2nd ed

  1995cited by this paper
• Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.

  1995cited by this paper
• Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

  1995cited by this paper
• Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.

  1994cited by this paper
• A high-sensitivity electrochemiluminescence-based detection system for automated PCR product quantitation.

  1993cited by this paper
• Detection of Epstein‐Barr virus in the brain by the polymerase chain reaction

  1992cited by this paper
• Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.

  1992cited by this paper
• Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

  1986cited by this paper

• Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation

  2024cites this paper
• Who is the patient at risk for EBV reactivation and disease: expert opinion focused on post-transplant lymphoproliferative disorders following hematopoietic stem cell transplantation

  2023cites this paper
• HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center

  2020cites this paper
• HLA-Mismatched GPBSCs infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: A observational study from a single center

  2020cites this paper
• Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives

  2020cites this paper
• Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation

  2019cites this paper
• Assessment of Immune Reconstitution Following Hematopoietic Stem Cell Transplantation

  2019cites this paper
• Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission

  2018cites this paper
• The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients

  2018cites this paper
• Managing post-transplant lymphoproliferative disorder

  2017cites this paper
• Iatrogenic immunodeficiency-associated lymphoproliferative disorders in transplant and nontransplant settings

  2016cites this paper
• Management of post‐transplant lymphoproliferative disorders

  2015cites this paper
• Research on the clinical effect and in vitro study of HLA-mismatched hematopoietic stem cell infusion for acute myeloid leukemia

  2015cites this paper
• Cancer–Testis Antigen 7 Expression and Immune Responses Following Allogeneic Stem Cell Transplantation for Multiple Myeloma

  2014cites this paper
• Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.

  2014cites this paper
• transplantation and donor lymphocyte infusions depleted hematopoietic stem cell − undergoing allogeneic T cell WT 1-specific T-cell responses in high-risk multiple myeloma patients

  2013cites this paper
• WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions.

  2013cites this paper
• immunosuppression, and immune recovery incidence and outcome in relation to graft manipulation, Adenovirus infections following allogeneic stem cell transplantation:

  2013cites this paper
• EBV reactivation and lymphoproliferative disease transplantation may identify patients at very high risk for progressive lymphocytes after partially T-depleted allogeneic stem cell specific CD8+ T -- Impaired recovery of Epstein-Barr virus (EBV)

  2013cites this paper
• Immune reconstitution after hematopoietic cell transplantation

  2012cites this paper
• The EBV-HIV interrelationship and the value of EBV-DNA analysis

  2012cites this paper
• The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation.

  2011cites this paper
• Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients.

  2011cites this paper
• Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders

  2011cites this paper
• disease following T-cell-depleted SCT cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem

  2010cites this paper
• Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders

  2010cites this paper
• Reconstitution immunitaire et immunothérapie adoptive anti-virales après allogreffe de cellules souches hématopoiétiques

  2010cites this paper
• Posttransplant Lymphoproliferative Disease (PTLD) in Hematopoietic Stem Cell Transplantation (HSCT)

  2010cites this paper
• Immunological reconstitution after hematopoietic cell transplantation – its relation to the contents of the graft

  2008cites this paper
• Epstein–Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients

  2008cites this paper
• Immunological reconstitution after hematopoietic cell transplantation - its relation to the contents of the graft.

  2008cites this paper
• Transplantation: Posttransplant Lymphoproliferative Disorder

  2007cites this paper
• Immune reconstitution following hematopoietic stem-cell transplantation.

  2007cites this paper
• The impact of monitoring Epstein–Barr virus PCR in paediatric bone marrow transplant patients: Can it successfully predict outcome and guide intervention?

  2006cites this paper
• Preemptive diagnosis and treatment of Epstein–Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development

  2006cites this paper
• Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray

  2006cites this paper
• Immune Reconstitution in Pediatric Patients Following Hematopoietic Stem-Cell Transplantation

  2006cites this paper
• Post-Transplant Lymphoproliferative Disorder in Children

  2005cites this paper
• Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients.

  2005cites this paper
• Post-transplant lymphoproliferative disorder.

  2005cites this paper
• Successful umbilical cord blood transplantation for severe chronic active Epstein‐Barr virus infection after the double failure of hematopoietic stem cell transplantation

  2005cites this paper
• Post-transplant lymphoproliferative disorder in children: incidence, prognosis, and treatment options.

  2005cites this paper
• In vitro Stimulation with WT1 Peptide-Loaded Epstein-Barr Virus-Positive B Cells Elicits High Frequencies of WT1 Peptide-Specific T Cells with In vitro and In vivo Tumoricidal Activity

  2004cites this paper
• Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus1

  2004cites this paper
• Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy.

  2004cites this paper
• Immunotherapy for Epstein – Barr Virus-Associated Tumors

  2004cites this paper
• Successful Unrelated Cord Blood Transplantation for Epstein-Barr Virus-Associated Lymphoproliferative Disease with Hemophagocytic Syndrome

  2004cites this paper
• Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells.

  2004cites this paper
• Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells.

  2003cites this paper
• ErythematosusVirus Infection in Systemic Lupus Defective Control of Latent Epstein-Barr

  2003influential citation
• Post-transplant lymphoproliferative disorder: a review

  2003cites this paper
• Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease.

  2003cites this paper
• T cell immunodeficiency and severe herpes virus infections after allogeneic stem cell transplantation

  2003cites this paper
• Posttransplant EBV-Associated Disease

  2003cites this paper
• Epstein–Barr virus associated disease following blood or marrow transplant

  2003influential citation
• Viral antigen‐specific CD8+ T‐cell responses are impaired in multiple myeloma

  2003cites this paper
• Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants: a review

  2003cites this paper
• Clinical Utility of Tetramer-Based Immune Monitoring in Allogeneic Stem Cell Transplantation

  2003cites this paper
• Role of Epstein-Barr Virus DNA Load Monitoring in Prevention and Early Detection of Post-transplant Lymphoproliferative Disease

  2002cites this paper
• Prevention and treatment of epstein–barr virus‐associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants

  2002cites this paper
• Epstein–Barr virus‐related lymphoproliferation in children after liver transplant: Role of immunity, diagnosis, and management

  2002cites this paper
• Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems.

  2002cites this paper
• Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors.

  2002cites this paper
• CD8 T Cells Inhibit IgE Via Dendritic Cell IL-12 Induction That Promotes Th1 T Cell Counter-Regulation1

  2002cites this paper
• Lymphoproliferation in Children After Liver Transplantation

  2002cites this paper
• Immunotherapy for Post‐Transplant Lymphoproliferative Disease

  2002cites this paper
• Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease1

  2002cites this paper
• Epstein-Barr virus ( EBV ) reactivation is a frequent event after allogeneic hematopoietic stem cell transplantation and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted stem cell transplantation

  2002cites this paper
• Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus.

  2002cites this paper
• Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery.

  2002cites this paper
• IL-12 Induction That Promotes Th 1 T Cell CD 8 T Cells Inhibit IgE Via Dendritic Cell

  2001cites this paper
• 3. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic hematopoietic stem cell transplantation and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted stem cell transplantation.

  2001cites this paper
• Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

  2001cites this paper
• Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference.

  2001cites this paper
• Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.

  2001cites this paper
• Counter-Regulation IL-12 Induction That Promotes Th1 T Cell CD8 T Cells Inhibit IgE Via Dendritic Cell

  2001cites this paper
• Successful in vitro generation of Epstein-Barr virus-specific cytotoxic T lymphocytes from severe chronic active EBV patients

  2001cites this paper
• Umbilical cord blood transplantation

  1999cites this paper